Stefania Meschini
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Cancer therapeutics and mechanisms 10
- DNA Repair Mechanisms 4
- RNA Interference and Gene Delivery 4
- Oncology 30
- Drug Transport and Resistance Mechanisms 20
- Co-authors
- Giuseppe Arancia (44 shared papers)Maria Condello (32 shared papers)Annarica Calcabrini (24 shared papers)Agnese Molinari (15 shared papers)Manuela Marra (12 shared papers)Annarita Stringaro (10 shared papers)Barbara De Berardis (4 shared papers)Pasquale Lista (4 shared papers)
- Journals
- International Journal of Cancer (5 papers)Toxicology in Vitro (4 papers)Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (3 papers)Journal of Experimental & Clinical Cancer Research (3 papers)MedChemComm (2 papers)
- Partner nations
- ItalyUnited StatesArmenia
In The Last Decade
Stefania Meschini
82 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 369
- Oncology 590
- Molecular Biology 1.3k
- Biomaterials 235
- Pharmacology 131
Countries citing papers authored by Stefania Meschini
This map shows the geographic impact of Stefania Meschini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Meschini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Meschini more than expected).
Fields of papers citing papers by Stefania Meschini
This network shows the impact of papers produced by Stefania Meschini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Meschini. The network helps show where Stefania Meschini may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefania Meschini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 271 | |
| 2 | 2004 | 156 | |
| 3 | 2010 | 151 | |
| 4 | 2010 | 132 | |
| 5 | 2016 | 127 | |
| 6 | 2007 | 112 | |
| 7 | 2019 | 94 | |
| 8 | 2015 | 80 | |
| 9 | 2016 | 78 | |
| 10 | 1994 | 78 | |
| 11 | 2011 | 77 | |
| 12 | 2002 | 73 | |
| 13 | 2015 | 70 | |
| 14 | 2003 | 67 | |
| 15 | 2000 | 67 | |
| 16 | 2002 | 62 | |
| 17 | 1999 | 60 | |
| 18 | 2008 | 59 | |
| 19 | 1998 | 56 | |
| 20 | 2009 | 54 |
About Stefania Meschini
Stefania Meschini is a scholar working on Molecular Biology, Oncology, Immunology, Epidemiology and Biomaterials, having authored 82 papers that have together received 3.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (20 papers), Cancer therapeutics and mechanisms (10 papers), Autophagy in Disease and Therapy (8 papers), Nanoparticle-Based Drug Delivery (7 papers), Nanoparticles: synthesis and applications (6 papers), DNA Repair Mechanisms (4 papers), RNA Interference and Gene Delivery (4 papers) and Toxin Mechanisms and Immunotoxins (4 papers). The work is most often cited by research in Cancer Research (369 citations), Oncology (590 citations), Molecular Biology (1.3k citations), Biomaterials (235 citations) and Pharmacology (131 citations). Stefania Meschini has collaborated with scholars based in Italy, United States and Armenia. Frequent co-authors include Giuseppe Arancia, Maria Condello, Annarica Calcabrini, Agnese Molinari, Manuela Marra, Annarita Stringaro, Barbara De Berardis, Pasquale Lista, Stefano Fais and Roberta Pozzi. Their work appears in journals such as International Journal of Cancer, Toxicology in Vitro, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, Journal of Experimental & Clinical Cancer Research and MedChemComm.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.